Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Craig J. Gibson"'
Autor:
Cristina Gasparetto, Mohit Narang, James W. Hardin, Robert M. Rifkin, Rafat Abonour, Sundar Jagannath, Howard R. Terebelo, Arlene S. Swern, Lynne I. Wagner, Kathleen Toomey, Brian G.M. Durie, Craig J. Gibson, Shankar Srinivasan, Amani Kitali
Publikováno v:
Annals of Hematology
Maintenance therapy after autologous stem cell transplantation (ASCT) is recommended for use in multiple myeloma (MM); however, more data are needed on its impact on health-related quality of life (HRQoL). Presented here is an analysis of HRQoL in a
Autor:
Dan T. Vogl, Kevin W. Song, Thierry Facon, Michel Delforge, Craig J. Gibson, Annette Ervin-Haynes, Shien Guo
Publikováno v:
Leukemia & Lymphoma. 59:398-405
The FIRST trial demonstrated that continuous therapy with lenalidomide and dexamethasone (Rd) prolongs overall survival (OS) and improves health-related quality of life (HRQoL) during the first 18 months of therapy in newly diagnosed multiple myeloma
Autor:
Shien Guo, Gary Binder, T. Facon, James D. Cavenagh, Darrell White, Andrew R. Belch, C G Pelligra, Yasir Nagarwala, Ariel Berger, Cyrille Hulin, Wai Yiu, Supratik Basu, Saad Z. Usmani, Ajay K. Nooka, Craig J. Gibson, Annette Ervin-Haynes
Publikováno v:
Journal of Medical Economics. 19:243-258
To conduct a cost-effectiveness assessment of lenalidomide plus dexamethasone (Rd) vs bortezomib plus melphalan and prednisone (VMP) as initial treatment for transplant-ineligible patients with newly-diagnosed multiple myeloma (MM), from a U.S. payer
Autor:
Steven R. Arikian, X. Henry Hu, Saad Z. Usmani, Andy Surinach, Frank A. Corvino, Yasir Nagarwala, Gary Binder, Mohamad A. Hussein, Craig J. Gibson, Dejan Milentijevic
Publikováno v:
Current Medical Research and Opinion. 31:1105-1115
Few studies have addressed the cost patterns of patients with multiple myeloma (MM) before and after first relapse. This US claims analysis evaluated, from a US health plan perspective, patterns of total direct costs of care from treatment initiation
Autor:
Sujith Dhanasiri, Steve Schey, Luis Felipe Casado Montero, Craig J. Gibson, Chloe Stengel-Tosetti
Publikováno v:
Oncology and Therapy
Introduction Lenalidomide is an active agent that was approved for use in the EU in 2015 as a first-line therapy for previously untreated, non-transplant eligible multiple myeloma patients. Our objective was to assess the cost impact of lenalidomide
Autor:
Kevin Hong, Katja Weisel, Craig J. Gibson, Mohamed H. Zaki, Meletios A. Dimopoulos, Owain Saunders, Kevin W. Song, Philippe Moreau, Lars Sternas
Publikováno v:
Leukemialymphoma. 57(12)
Relapsed/refractory multiple myeloma (RRMM) patients have poor overall survival (OS). Pomalidomide plus low-dose dexamethasone (POM + LoDEX) significantly extends OS in RRMM vs. high-dose dexamethasone. Survival of patients with stable disease (SD) w
Autor:
James W. Hardin, Kathleen Toomey, Jatin P. Shah, Arlene S. Swern, Brian G.M. Durie, Cristina Gasparetto, Shankar Srinivasan, Rafat Abonour, Amani Kitali, Sundar Jagannath, Robert M. Rifkin, Howard R. Terebelo, Mohit Narang, Craig J. Gibson
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 17:e89-e90
Publikováno v:
The Journal of Neuroscience. 27:13813-13821
The inositol 1,4,5-trisphosphate (InsP3) receptor type I (InsP3R-I) is the principle channel for intracellular calcium (Ca2+) release in many cell types, including central neurons. It is regulated by endogenous compounds like Ca2+and ATP, by protein
Autor:
Kevin W. Song, Mohamed H. Zaki, Jesús F. San Miguel, Katja Weisel, Pieter Sonneveld, Stephen Schey, Christian Jacques, Antonio Palumbo, Andrew R. Belch, Craig J. Gibson, Philippe Moreau, Lars Sternas, Meletios A. Dimopoulos, Xin Yu, Ramesh Amatya
Publikováno v:
Clinical Lymphoma Myeloma & Leukemia, 15(9), 519-530. Cancer Media Group
Background Health-related quality of life (HRQoL) is an important element for consideration in treatment decisions in patients with relapsed/refractory multiple myeloma (RRMM). The pivotal MM-003 (A Phase 3, Multicenter, Randomized, Open-Label Study
Autor:
Craig J. Gibson, Kathleen McGlynn, Michael C. Lawrence, Wei Chen, Colleen A. Vanderbilt, Tara Beers Gibson, Marlon F. Levy, Bashoo Naziruddin, Don Arnette, Melanie H. Cobb, Barbara E. Ehrlich, Julie Collins
Publikováno v:
Diabetes. 55:1066-1073
Glucose sensing is essential for the ability of pancreatic beta-cells to produce insulin in sufficient quantities to maintain blood glucose within the normal range. Stress causes the release of adrenergic hormones that increase circulating glucose by